Evidence map›Paper›PMID 26794278›Full record

Observational studyBritish journal of cancer2016

HPV immunisation and increased uptake of cervical screening in Scottish women; observational study of routinely collected national data.

T J Palmer, M McFadden, K G J Pollock, K Kavanagh, K Cuschieri, M Cruickshank, S Nicoll, C Robertson

Open access · hybridAbstract readObservational Study
In one paragraph

Observational study in British journal of cancer, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Health-related quality of life as measured by the EQ-5D in the prevention, screening and management of cervical disease: A systematic review.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2017
    Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 7 institutions in 2 countries.

T J PalmerDepartment of Pathology, University of Edinburgh, EH16 4SA, University of Edinburgh, Edinburgh, Scotland.
M McFaddenInformation Services Division, NHS National Services Scotland, Gyle Square, Edinburgh EH12 9EB, UK.
K G J PollockHealth Protection Scotland, Glasgow G2 6QE, Scotland.
K KavanaghDepartment of Mathematics and Statistics, University of Strathclyde, Glasgow G1 1XH, Scotland.
K CuschieriScottish Human Papillomavirus Reference Laboratory, Royal Infirmary of Edinburgh, Edinburgh EH16 4SA, Scotland.
M CruickshankDepartment of Gynaecology, Aberdeen Royal Infirmary, Aberdeen AB25 2ZD, Scotland.
S NicollDepartment of Cytology, Ninewells Hospital, Dundee DD1 9SY, Scotland.
C RobertsonHealth Protection Scotland, Glasgow G2 6QE, Scotland.
Health Protection Scotland · GBAberdeen Royal Infirmary · GBEdinburgh Royal Infirmary · GBNational Health Service Scotland · GBNinewells Hospital · GBUniversity of Edinburgh · GBUniversity of Strathclyde · GB

Funding

Chief Scientist Office CZH/4/528
6 · The paper itself

Abstract

backgroundTo measure the uptake of first invitation to cervical screening by vaccine status in a population-based cohort offered HPV immunisation in a national catch-up campaign.

methodsA retrospective observational study of routinely collected data from the Scottish Cervical Screening Programme. Data were extracted and linked from the Scottish Cervical Call Recall System, the Scottish Population Register and the Scottish Index of Multiple Deprivation. Records from 201 023 women born between 1 January 1988 and 30 September 1993 were assessed. Women born in or after 1990 were eligible for the national catch-up programme of HPV immunisation. Attendance for screening was within 12 months of the first invitation at age 20 years.

resultsThere was a significant decline in overall attendance from the 1988 cohort to the 1993 cohort with the adjusted attendance ratio of the 1988 cohort being 1.49 times (95% CI 1.46-1.52) that of the 1993 cohort. Immunisation compensated for this decrease in uptake with unvaccinated individuals having a reduced ratio of attendance compared with those fully vaccinated (RR=0.65, 95% CI 0.64-0.65). Not taking up the opportunity for HPV immunisation was associated with an attendance for screening below the trend line for all women before the availability of HPV immunisation.

conclusionsHPV immunisation is not associated with the reduced attendance for screening that had been feared. Immunised women in the catch-up cohorts appear to be more motivated to attend than unimmunised women, but this may be a result of a greater awareness of health issues. These results, while reassuring, may not be reproduced in routinely immunised women. Continued monitoring of attendance for the first smear and subsequent routine smears is needed.

Indexed as

Case-Control StudiesEarly Detection of CancerFemaleHumansPapillomavirus InfectionsPapillomavirus VaccinesRetrospective StudiesScotlandUterine Cervical NeoplasmsYoung AdultPapillomavirus Vaccines

Identifiers

PMID26794278
PMCPMC4782202
OpenAlexW2292019119

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.